HAVN Life Secures Purchase Order for Controlled Substance Sale to Revive...
Revive Therapeutics Signs Supply Agreement With Havn Life Sciences for Psychedelic Compounds Expanding research and development of naturally-derived psilocybin for future FDA...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0.03 | 0.03 | 0.03 | 0 | 0 | CS |
4 | 0 | 0 | 0.03 | 0.03 | 0.03 | 0 | 0 | CS |
12 | 0 | 0 | 0.03 | 0.03 | 0.03 | 0 | 0 | CS |
26 | 0 | 0 | 0.03 | 0.03 | 0.03 | 0 | 0 | CS |
52 | 0 | 0 | 0.03 | 0.03 | 0.03 | 0 | 0 | CS |
156 | -0.135 | -81.8181818182 | 0.165 | 2 | 0.015 | 105485 | 0.06649715 | CS |
260 | -0.47 | -94 | 0.5 | 2 | 0.015 | 190681 | 0.51068004 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約